Herpesviruses and the microbiome

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 6, 2013, Pages 1278-1286

  Dreyfus, David H ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Center for Allergy Asthma and Immunology   (United States)

Author keywords

genomics; herpes; Hygiene hypothesis; microbiome; therapy; vaccines

Indexed keywords

ACICLOVIR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; MICRORNA; SMALL INTERFERING RNA; VARICELLA ZOSTER VACCINE;

ARTICLE; ATOPY; AUTOIMMUNE DISEASE; CHILDHOOD DISEASE; CLINICAL OBSERVATION; CYTOMEGALOVIRUS; DIAGNOSTIC ERROR; DRESS SYNDROME; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HERPES VIRUS INFECTION; HERPES ZOSTER; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; IMMUNE RESPONSE; INFECTION SENSITIVITY; KAPOSI VARICELLIFORM ERUPTION; MICROBIOME; PRIORITY JOURNAL; TH2 CELL; VARICELLA ZOSTER VIRUS; VIRAL SKIN DISEASE; VIRUS EXPRESSION; VIRUS REACTIVATION;

CMV; CYTOMEGALOVIRUS; DRESS; DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS; EBNA; EPSTEIN-BARR NUCLEAR ANTIGEN; GENOMICS; HERPES; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS TYPE 1, ALSO KNOWN AS HHV1 (HUMAN HERPES VIRUS TYPE 1); HERPES SIMPLEX VIRUS TYPE 2, ALSO KNOWN AS HHV2 (HUMAN HERPES VIRUS TYPE 2); HSV; HSV1; HSV2; HYGIENE HYPOTHESIS; KAPOSI SARCOMA VIRUS; KSV; MICROBIOME; THERAPY; VACCINES; VARICELLA ZOSTER VIRUS; VIL-10; VIRAL IL-10-LIKE PROTEIN ENCODED BY EBV; VZV (OR HHV3);

ANIMALS; CHILD; GENE-ENVIRONMENT INTERACTION; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; HYPERSENSITIVITY; IMMUNOMODULATION; MICROBIOTA; SKIN;

EID: 84888643684     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.02.039     Document Type: Article

References (104)

1. K.M. James, R.S. Peebles Jr., and T.V. Hartert Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility? J Allergy Clin Immunol 130 2012 343 351
2. E. von Mutius A fascinating look at the world with a new microscope J Allergy Clin Immunol 129 2012 1202 1203
3. D.H. Hsu, R. de Waal Malefyt, D.F. Fiorentino, M.N. Dang, P. Vieira, and J. de Vries Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1 Science 250 1990 830 832
4. I.A. MacNeil, T. Suda, K.W. Moore, T.R. Mosmann, and A. Zlotnik IL-10, a novel growth cofactor for mature and immature T cells J Immunol 145 1990 4167 4173
5. K.W. Moore, P. Vieira, D.F. Fiorentino, M.L. Trounstine, T.A. Khan, and T.R. Mosmann Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI Science 248 1990 1230 1234
6. R.D. Irons, and A.T. Le Dithiocarbamates and viral IL-10 collaborate in the immortalization and evasion of immune response in EBV-infected human B lymphocytes Chem Biol Interact 172 2008 81 92
7. K. Kanai, Y. Satoh, H. Yamanaka, A. Kawaguchi, K. Horie, and K. Sugata The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates Virus Genes 35 2007 563 569
8. K.S. Voo, G. Peng, Z. Guo, T. Fu, Y. Li, and L. Frappier Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation Cancer Res 65 2005 1577 1586
9. P. Bager, T. Westergaard, K. Rostgaard, N.M. Nielsen, M. Melbye, and P. Aaby Smallpox vaccination and risk of allergy and asthma J Allergy Clin Immunol 111 2003 1227 1231
10. R.J. Engler, J. Kenner, and D.Y. Leung Smallpox vaccination: risk considerations for patients with atopic dermatitis J Allergy Clin Immunol 110 2002 357 365
11. H. Milgrom, E. Palmer, and D. Leung Smallpox vaccination: a conundrum of risks and outcomes Curr Opin Allergy Clin Immunol 5 2005 207 209
12. N.M. Alcantara-Neves, R.V. Veiga, V.C. Dattoli, R.L. Fiaccone, R. Esquivel, and A.A. Cruz The effect of single and multiple infections on atopy and wheezing in children J Allergy Clin Immunol 129 2012 359 367 e1-3
13. C. Janson, H. Asbjornsdottir, A. Birgisdottir, R.B. Sigurjonsdottir, M. Gunnbjornsdottir, and D. Gislason The effect of infectious burden on the prevalence of atopy and respiratory allergies in Iceland, Estonia, and Sweden J Allergy Clin Immunol 120 2007 673 679
14. M.F. Moffatt, M. Kabesch, L. Liang, A.L. Dixon, D. Strachan, and S. Heath Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma Nature 448 2007 470 473
15. C. Nilsson, A.K. Larsson Sigfrinius, S.M. Montgomery, E. Sverremark-Ekstrom, A. Linde, and G. Lilja Epstein-Barr virus and cytomegalovirus are differentially associated with numbers of cytokine-producing cells and early atopy Clin Exp Allergy 39 2009 509 517
16. A.L. Ponsonby, T. Dwyer, I. van der Mei, A. Kemp, L. Blizzard, and B. Taylor Asthma onset prior to multiple sclerosis and the contribution of sibling exposure in early life Clin Exp Immunol 146 2006 463 470
17. R.V. Veiga, S.S. Cunha, V.C. Dattoli, A.C. Cruz, P.J. Cooper, and L.C. Rodrigues Chronic virus infections suppress atopy but not asthma in a set of children from a large Latin American city: a cross-section study BMC Pulm Med 11 2011 24
18. D.H. Dreyfus Autoimmune disease: a role for new anti-viral therapies? Autoimmun Rev 11 2011 88 97
19. D.H. Dreyfus, C.A. Kelleher, J.F. Jones, and E.W. Gelfand Epstein-Barr virus infection of T cells: implications for altered T-lymphocyte activation, repertoire development and autoimmunity Immunol Rev 152 1996 89 110
20. Y. Liu, R. de Waal Malefyt, F. Briere, C. Parham, J.M. Bridon, and J. Banchereau The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor J Immunol 158 1997 604 613
21. P.R. Beatty, S.M. Krams, and O.M. Martinez Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines J Immunol 158 1997 4045 4051
22. L.L. Kis, M. Takahara, N. Nagy, G. Klein, and E. Klein IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines Blood 107 2006 2928 2935
23. M. Nishimura, H. Sato, H. Okazaki, M. Satake, and K. Tadokoro Interleukin-10 containing normal human serum inhibits granzyme B release but not perforin release from alloreactive and EBV-specific T cell clones Cell Immunol 251 2008 31 36
24. J.M. Wroblewski, A. Copple, L.P. Batson, C.D. Landers, and J.R. Yannelli Cell surface phenotyping and cytokine production of Epstein-Barr Virus (EBV)-transformed lymphoblastoid cell lines (LCLs) J Immunol Methods 264 2002 19 28
25. D.H. Dreyfus, Y. Liu, L.Y. Ghoda, and J.T. Chang Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-kappaB and p53 Virol J 8 2011 422
26. C. Gourzones, A. Gelin, I. Bombik, J. Klibi, B. Verillaud, and J. Guigay Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells Virol J 7 2010 271
27. G. Malterer, L. Dolken, and J. Haas The miRNA-targetome of KSHV and EBV in human B-cells RNA Biol 8 2011 30 34
28. W. Peng, O. Vitvitskaia, D. Carpenter, S.L. Wechsler, and C. Jones Identification of two small RNAs within the first 1.5-kb of the herpes simplex virus type 1-encoded latency-associated transcript J Neurovirol 14 2008 41 52
29. J. van Beek, A. zur Hausen, S.N. Snel, J. Berkhof, E.K. Kranenbarg, and C.J. van de Velde Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases Am J Surg Pathol 30 2006 59 65
30. D.B. Bloch, R. Nobre, A.U. Steinbicker, W. Al-Herz, L.D. Notarangelo, and M. Recher Decreased IL-10 production by EBV-transformed B cells from patients with VODI: implications for the pathogenesis of Crohn disease J Allergy Clin Immunol 129 2012 1678 1680
31. C.Q. Jin, F. Liu, H.X. Dong, J. Zhang, J.W. Zhou, and L. Song Type 2 polarized immune response holds a major position in Epstein-Barr virus-related idiopathic thrombocytopenic purpura (EBV-ITP) Int J Lab Hematol 34 2012 164 171
32. C. Minnicelli, M.H. Barros, C.E. Klumb, S.O. Romano, I.R. Zalcberg, and R. Hassan Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma PLoS One 7 2012 e46005
33. S.Y. Zhang, E. Jouanguy, S. Ugolini, A. Smahi, G. Elain, and P. Romero TLR3 deficiency in patients with herpes simplex encephalitis Science 317 2007 1522 1527
34. K.F. Bryant, Z. Yan, D.H. Dreyfus, and D.M. Knipe Identification of a divalent metal cation binding site in herpes simplex virus 1 (HSV-1) ICP8 required for HSV replication J Virol 86 2012 6825 6834
35. K.J. Thomson, D.P. Hart, L. Banerjee, K.N. Ward, K.S. Peggs, and S. Mackinnon The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation Bone Marrow Transplant 35 2005 1065 1069
36. M.S. Patel, A. Gebremariam, and M.M. Davis Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States Infect Control Hosp Epidemiol 29 2008 1157 1163
37. M. Brisson, W.J. Edmunds, and N.J. Gay Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV J Med Virol 70 suppl 1 2003 S31 S37
38. M. Brisson, W.J. Edmunds, N.J. Gay, and E. Miller Varicella vaccine and shingles JAMA 287 2002 2211 author reply 2212
39. S.S. Chaves, P. Haber, K. Walton, R.P. Wise, H.S. Izurieta, and D.S. Schmid Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005 J Infect Dis 197 suppl 2 2008 S170 S177
40. C.B. Good Varicella-zoster vaccine N Engl J Med 357 2007 89
41. S. Hambleton Prevention of varicella and zoster by live attenuated VZV vaccine Front Biosci 13 2008 2696 2704
42. S. Hambleton, S.P. Steinberg, P.S. Larussa, E.D. Shapiro, and A.A. Gershon Risk of herpes zoster in adults immunized with varicella vaccine J Infect Dis 197 suppl 2 2008 S196 S199
43. N. Macaladad, T. Marcano, M. Guzman, J. Moya, F. Jurado, and M. Thompson Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults Vaccine 25 2007 2139 2144
44. M. Takahashi, Y. Asano, H. Kamiya, K. Baba, T. Ozaki, and T. Otsuka Development of varicella vaccine J Infect Dis 197 suppl 2 2008 S41 S44
45. J.I. Silverberg, K.B. Norowitz, E. Kleiman, N.B. Silverberg, H.G. Durkin, and R. Joks Association between varicella zoster virus infection and atopic dermatitis in early and late childhood: a case-control study J Allergy Clin Immunol 126 2010 300 305
46. A. Weinberg, J.H. Zhang, M.N. Oxman, G.R. Johnson, A.R. Hayward, and M.J. Caulfield Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine J Infect Dis 200 2009 1068 1077
47. A.M. Sartori A review of the varicella vaccine in immunocompromised individuals Int J Infect Dis 8 2004 259 270
48. T. Verstraeten, A.O. Jumaan, J.P. Mullooly, J.F. Seward, H.S. Izurieta, and F. DeStefano A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination Pediatrics 112 2003 e98 103
49. H.F. Tseng, N. Smith, S.M. Marcy, L.S. Sy, and S.J. Jacobsen Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2002-2008 Pediatr Infect Dis J 28 2009 1069 1072
50. B. Uebe, A. Sauerbrei, S. Burdach, and G. Horneff Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child Eur J Pediatr 161 2002 442 444
51. M. Vazquez Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine Curr Opin Pediatr 16 2004 80 84
52. K. Choong, L. Zwaigenbaum, and H. Onyett Severe varicella after low dose inhaled corticosteroids Pediatr Infect Dis J 14 1995 809 811
53. K. Murphy, K. Ververeli, B.M. Harvey, A.L. Duke, J. Chapas-Crilly, and T. Uryniak Antibody response after varicella vaccination in children treated with budesonide inhalation suspension or non-steroidal conventional asthma therapy Int J Clin Pract 60 2006 1548 1557
54. S.J. Szefler, E. Lyzell, S. Fitzpatrick, and M. Cruz-Rivera Safety profile of budesonide inhalation suspension in the pediatric population: worldwide experience Ann Allergy Asthma Immunol 93 2004 83 90
55. S.F. Dowell, and J.S. Bresee Severe varicella associated with steroid use Pediatrics 92 1993 223 228
56. N.J. Luca, I. Lara-Corrales, and E. Pope Eczema herpeticum in children: clinical features and factors predictive of hospitalization J Pediatr 161 2012 671 675
57. A. Wollenberg Eczema herpeticum Chem Immunol Allergy 96 2012 89 95
58. P.L. Aronson, S.S. Shah, Z. Mohamad, and A.C. Yan Topical corticosteroids and hospital length of stay in children with eczema herpeticum Pediatr Dermatol 30 2013 215 221
59. P.L. Aronson, A.C. Yan, Z. Mohamad, M.K. Mittal, and S.S. Shah Empiric antibiotics and outcomes of children hospitalized with eczema herpeticum Pediatr Dermatol 30 2013 207 214
60. P.S. Gao, D.Y. Leung, N.M. Rafaels, M. Boguniewicz, T. Hand, and L. Gao Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum J Invest Dermatol 132 2012 650 657
61. V. Sancho-Shimizu, R. Perez de Diego, L. Lorenzo, R. Halwani, A. Alangari, and E. Israelsson Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency J Clin Invest 121 2011 4889 4902
62. Y. Guo, M. Audry, M. Ciancanelli, L. Alsina, J. Azevedo, and M. Herman Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity J Exp Med 208 2011 2083 2098
63. M. Audry, M. Ciancanelli, K. Yang, A. Cobat, H.H. Chang, and V. Sancho-Shimizu NEMO is a key component of NF-kappaB- and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus J Allergy Clin Immunol 128 2011 610 617 e1-4
64. L. Abel, S. Plancoulaine, E. Jouanguy, S.Y. Zhang, N. Mahfoufi, and N. Nicolas Age-dependent Mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood J Pediatr 157 2010 623 629.e1
65. V. Sancho-Shimizu, S.Y. Zhang, L. Abel, M. Tardieu, F. Rozenberg, and E. Jouanguy Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans Curr Opin Allergy Clin Immunol 7 2007 495 505
66. A. Casrouge, S.Y. Zhang, C. Eidenschenk, E. Jouanguy, A. Puel, and K. Yang Herpes simplex virus encephalitis in human UNC-93B deficiency Science 314 2006 308 312
67. R.A. Rezende, T. Bisol, K. Hammersmith, C.J. Rapuano, A.L. Lima, and G.F. Webster Efficacy of oral antiviral prophylaxis in preventing ocular herpes simplex virus recurrences in patients with and without self-reported atopy Am J Ophthalmol 142 2006 563 567
68. R.A. Rezende, K. Hammersmith, T. Bisol, A.L. Lima, G.F. Webster, and J.F. Freitas Comparative study of ocular herpes simplex virus in patients with and without self-reported atopy Am J Ophthalmol 141 2006 1120 1125
69. R.A. Rezende, T. Bisol, K. Hammersmith, A.L. Hofling-Lima, G.F. Webster, and J.F. Freitas Epithelial herpetic simplex keratitis recurrence and graft survival after corneal transplantation in patients with and without atopy Am J Ophthalmol 143 2007 623 628
70. I. Hussain, and J. Smith Evidence for the transmissibility of atopy: hypothesis Chest 124 2003 1968 1974
71. M. Igde, F.A. Igde, and Z. Yazici Herpes simplex type I infection and atopy association in Turkish children with asthma and allergic rhinitis Iran J Allergy Asthma Immunol 8 2009 149 154
72. L.C. von Hertzen, T. Laatikainen, M.J. Makela, P. Jousilahti, T.U. Kosunen, and T. Petays Infectious burden as a determinant of atopy - a comparison between adults in Finnish and Russian Karelia Int Arch Allergy Immunol 140 2006 89 95
73. L.C. von Hertzen, P.T. Pekkarinen, T. Laatikainen, M.J. Makela, and T. Haahtela Herpes simplex virus and atopy in Finnish and Russian Karelian children Eur Respir J 30 2007 809 810
74. P.M. Matricardi, F. Rosmini, S. Riondino, M. Fortini, L. Ferrigno, and M. Rapicetta Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study BMJ 320 2000 412 417
75. S.Y. Yang, M.J. Chen, K.H. Chen, A.F. Li, C.K. Chou, and S.M. Lee Cytomegalovirus and herpes simplex virus as causes of bilateral anterior uveitis in an immunocompetent patient J Chin Med Assoc 74 2011 48 50
76. S. Botto, D.N. Streblow, V. DeFilippis, L. White, C.N. Kreklywich, and P.P. Smith IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin Blood 117 2011 352 361
77. K. Sacre, P.W. Hunt, P.Y. Hsue, E. Maidji, J.N. Martin, and S.G. Deeks A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus- induced T-cell immunopathology in HIV-associated atherosclerosis AIDS 26 2012 805 814
78. R. Alam The burden of allergic rhinitis beyond allergies Immunol Allergy Clin North Am 31 2011 ix x
79. R. De Caterina, and A. Zampolli From asthma to atherosclerosis - 5-lipoxygenase, leukotrienes, and inflammation N Engl J Med 350 2004 4 7
80. N.M. Abdel-Haq, and B.I. Asmar Human herpesvirus 6 (HHV6) infection Indian J Pediatr 71 2004 89 96
81. E. Caselli, and D. Di Luca Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7 New Microbiol 30 2007 173 187
82. K.N. Ward Human herpesviruses-6 and -7 infections Curr Opin Infect Dis 18 2005 247 252
83. K.N. Ward The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent J Clin Virol 32 2005 183 193
84. K.N. Ward, N.J. Andrews, C.M. Verity, E. Miller, and E.M. Ross Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland Arch Dis Child 90 2005 619 623
85. D.M. Zerr Human herpesvirus 6 (HHV-6) disease in the setting of transplantation Curr Opin Infect Dis 25 2012 438 444
86. J.H. Arbuckle, M.M. Medveczky, J. Luka, S.H. Hadley, A. Luegmayr, and D. Ablashi The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro Proc Natl Acad Sci U S A 107 2010 5563 5568
87. R. Ciccocioppo, F. Baldanti, M. Russo, L. Chezzi, F. Viola, and M. Aloi Human herpes virus-6 chromosomal integration misled the management of Crohn's disease Inflamm Bowel Dis 17 2011 E113 E115
88. K. Aouam, H. Bel Hadj Ali, M. Youssef, A. Chaabane, M. Amri, and N.A. Boughattas Carbamazepine-induced DRESS and HHV6 primary infection: the importance of skin tests Epilepsia 49 2008 1630 1633
89. P.R. Criado, R.F. Criado, M. Avancini Jde, and C.G. Santi Drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts An Bras Dermatol 87 2012 435 449
90. Y. Hamaguchi, M. Fujimoto, Y. Enokido, T. Wayaku, K. Kaji, and T. Echigo Intractable genital ulcers from herpes simplex virus reactivation in drug-induced hypersensitivity syndrome caused by allopurinol Int J Dermatol 49 2010 700 704
91. H. Morito, K. Kitamura, T. Fukumoto, N. Kobayashi, M. Kuwahara, and H. Asada Drug eruption with eosinophilia and systemic syndrome associated with reactivation of human herpesvirus 7, not human herpesvirus 6 J Dermatol 39 2012 669 670
92. D. Bonekamp, K.M. Horton, R.H. Hruban, and E.K. Fishman Castleman disease: the great mimic Radiographics 31 2011 1793 1807
93. E. Caselli, S. Fiorentini, C. Amici, D. Di Luca, A. Caruso, and M.G. Santoro Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary-like structure formation: role of the IKK/NF-kappaB pathway Blood 109 2007 2718 2726
94. E. Caselli, D. Padovani, R. Di Carlo, E. Grandi, M. Galvan, and E. Cassai Parotid localized Castleman's disease and HHV-8 infection: a case report Eur Arch Otorhinolaryngol 265 2008 377 380
95. K.M. Tamburro, D. Yang, J. Poisson, Y. Fedoriw, D. Roy, and A. Lucas Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A Virology 433 2012 220 225
96. A.D. Breithaupt, A. Di Nardo, and S.J. Kempiak What is your diagnosis? The diagnosis: Kaposi varicelliform eruption (eczema herpeticum) Cutis 90 13 2012 24 25
97. V.A. Morris, A.S. Punjabi, R.C. Wells, C.J. Wittkopp, R. Vart, and M. Lagunoff The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation Virology 428 2012 112 120
98. N. Merindol, I. Salem Fourati, R.M. Brito, A.J. Grenier, E. Charrier, and P. Cordeiro Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation J Immunol 189 2012 5016 5028
99. D.H. Dreyfus Paleo-immunology: evidence consistent with insertion of a primordial herpes virus-like element in the origins of acquired immunity PLoS One 4 2009 e5778
100. A. Getahun, M.J. Smith, I. Kogut, L.F. van Dyk, and J.C. Cambier Retention of anergy and inhibition of antibody responses during acute gammaherpesvirus 68 infection J Immunol 189 2012 2965 2974
101. D.T. Umetsu, and R.H. Dekruyff Regulation of tolerance in the respiratory tract: TIM-1, hygiene, and the environment Ann N Y Acad Sci 1029 2004 88 93
102. D.T. Umetsu, J.J. McIntire, O. Akbari, C. Macaubas, and R.H. DeKruyff Asthma: an epidemic of dysregulated immunity Nat Immunol 3 2002 715 720
103. V. Descamps, F. Bouscarat, S. LaGlenne, E. Aslangul, B. Veber, and D. Descamps Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome Br J Dermatol 137 1997 605 608
104. D. Picard, B. Janela, V. Descamps, M. D'Incan, P. Courville, and S. Jacquot Drug Reaction with eosinophilia and systemic symptoms (DRESS): a multi-organ antiviral T cell response Sci Transl Med 2 2010 46ra62h